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Total Elbow Arthroplasty: A Prospective Clinical Outcome Study of Discovery Elbow 1 
System with a 4-Year Mean Follow-Up 2 
Abstract 3 
Background: Total elbow arthroplasty (TEA) is increasingly used for the treatment of 4 
advanced elbow conditions to reduce pain and improve function. However, TEA is still 5 
associated with a higher complication rate compared to the total hip and knee arthroplasty 6 
despite advances in the design and surgical techniques. This prospective clinical study reports 7 
the outcome of the Discovery Elbow System (Biomet Inc., Warsaw IN, USA) system which 8 
has been in clinical use in the UK since 2003.  9 
 10 
Methods: The study included a total of 100 Discovery elbows (April 2003 to January 2010) 11 
with a minimum 2-year follow-up including 75 primary and 25 revisions (60 % females and 12 
40% males; mean age, 62 years). Outcome was assessed by means of Liverpool Elbow Score, 13 
pain experience, patient satisfaction, range of movement, and radiographic imaging.  14 
 15 
Results: Mean follow-up was 48.5 months (range: 24-108 months). Liverpool Elbow Score   16 
improved from 3.79 to 6.36 (P<.001). Pain-free patients were substantially increased form 17 
7% preoperatively to 64% at the final follow-up. Patient satisfaction rate was over 90%. The 18 
arc of flexion-extension and pronation-supination increased from 72º to 93º and from 86º to 19 
111º, respectively (P<.001). Major post-operative complications included deep infection 20 
(2%), progressive aseptic loosening requiring revision (primary, 5%; revision 12%), 21 
persistent ulnar neuropathy (3%), and periprosthetic fracture (primary, 6.8%; revision, 8%).  22 
 23 
Conclusion: Discovery elbow resulted in improved function, reduced pain, and high patient 24 
satisfaction. Long-term results are required for assessing the survivorship of this system.  25 
 26 
Keywords: Total Elbow Arthroplasty; Discovery Elbow; Clinical Outcome; Elbow 27 
Prostheses.  28 
Level of Evidence: Level III 29 
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BACKGROUND 30 
Total elbow arthroplasty (TEA) has increasingly become a popular reconstructive procedure 31 
due to improved surgical techniques, advanced implant designs, and enhanced clinical 32 
outcomes.39 The modern era of TEA began in the late 1970s when the prosthetic design 33 
evolved following several key developments: the use of high-density polyethylene as a 34 
bearing surface to metal, the use of methyl methacrylate bone cement, and the 35 
implementation of biomechanical science to reproduce normal joint kinematics.7 Modern 36 
TEA implants are designed as linked or unlinked. Linked implants are coupled together 37 
through a hinge allowing for some degrees of laxity in the medial, lateral, and rotational 38 
planes consistent with normal elbow kinematics. A “sloppy hinge,” design is associated with 39 
a reduced rate of aseptic loosening and instability of the articulation.34 Unlinked implants are 40 
not mechanically coupled and mostly rely on matching shapes of the bearing surfaces, 41 
adequate bone stock, and, the integrity of capsular and ligamentous structures.5,7 Unlinked 42 
designs have been associated with higher rate of instability as their stability mainly depends 43 
on their geometry and surrounding soft tissues (ligaments and bone stock) rather than the 44 
intrinsic constraint of the articulation.5 45 
 46 
The use of unlinked prostheses may be preferred when there is less bone or articular 47 
destruction and in younger patients who may need later revision surgery. To the other hand, 48 
the increased stability of the linked implants has expanded their use in conditions with 49 
increased bone destruction and ligamentous incompetency such as advanced stages of 50 
rheumatoid arthritis, posttraumatic and degenerative osteoarthritis, and complex distal 51 
humerus and intra-articular fractures (particularly in elderly patients).5,7,22 52 
 53 
Despite considerable developments in the prosthetic design, TEA has been associated with a 54 
high rate of complications, ranging from 20% to 45%, compared to other main total joint (hip 55 
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and knee) replacements15,27,41 potentially because of the difficulty of surgical procedure in a 56 
complex joint with minimal soft tissue support.10 Gschwend et al,15 reviewed the literature 57 
and reported an overall complication rate of up to 43% including aseptic loosening, 58 
infections, ulnar nerve complications, instability, disassembly, dislocation, subluxation, 59 
intraoperative fractures, fractures of the prosthesis, implant loosening, periprosthetic fracture, 60 
triceps insufficiency, and ectopic bone formation. In another review, Little et al,27 reported an 61 
overall complication rate of 14%-80% with a median rate of 33%.  62 
 63 
In terms of more specific complications, polyethylene bushing failure/wear 16,25,27,34 and hinge 64 
failure14, 25 have been associated with the earlier designs of the linked prostheses. While 65 
linked, semiconstrained prostheses with a “sloppy” hinge linkage system were designed to 66 
protect against loosening and to allow for their use in the presence of significant bone or 67 
ligamentous deficiency;17 the earlier designs have been associated with a high rate of bushing 68 
failure (14% to 47%) because of using polyethylene-type bushings which can result in 69 
particulate polyethylene-induced synovitis, osteolysis, and implant loosening.14,17,26,30,44 In 70 
addition to bushing failure, other types of mechanical failures including disassembly and 71 
failure of the hinge locking mechanism have been described in relation to commonly used 72 
semiconstrained linked prostheses such as the Coonrad-Morrey12,37,44 and GSBIII.15  73 
 74 
The Discovery ™ Elbow System (Biomet Inc, Warsaw, IN, USA) was designed to address 75 
specific complications associated with the earlier designs by providing more accurate 76 
positioning of the elbow flexion/extension axis; ensuring stability without employing a true 77 
hinge; distributing contact forces over large condylar surfaces; and preserving the ulnar 78 
collateral ligament.17,18 Furthermore, assembling chrome cobalt condyles that connect the 79 
humeral and ulnar components after cementing preserves the humeral condyles. These design 80 
characteristics is expected to reduce the rate of polyethylene bushing wear, reinforce 81 
anatomic stem design, restore natural elbow joint biomechanics, and produce a hinge that 82 
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could be easily revised.17 The Discovery elbow has been in clinical use in the UK since 2003. 83 
The structural specifications and design rationale of the system have been described in full 84 
details by Hastings and Theng19 and Hastings.17  85 
 86 
This study aimed to 1) report functional and radiological outcome of the Discovery elbow in 87 
a large series of primary and revision TEAs with various elbow pathologies; and 2) compare 88 
the clinical outcome and complications with published literature on other prostheses.  89 
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PATIENTS AND METHODS 90 
One hundred Discovery elbows with a minimum 2-year follow-up were included in the study. 91 
All TEAs were performed in a single centre by the same surgeon (April 2003 to January 92 
2010). The technical properties of the prosthetic system and surgical technique have been 93 
described in full details by Hastings et al.17  94 
The mean age of patients (females, 60 %; males, 40%) was 62 years (range: 22-86), weight 95 
71.8kg (±18.3), and height 166 (±12.5). The mean follow-up period was 48.5 months (range: 96 
24-108 months). Inclusion criteria were advanced arthritis unresponsive to non-operative 97 
management, acute distal humerus fracture and revision for loosening of other elbow 98 
prostheses in skeletally mature patients (>18 years old). Exclusion criteria included 99 
systematic metabolic diseases affecting the bone formation and active infection. The main 100 
underlying pathologies (diagnoses) are outlined in Table1. Primary and revision TEA 101 
comprised 75% and 25% of the cases, respectively. Study received approval from a local 102 
research ethics committee and all patients gave informed consent prior to the surgery.  103 
 104 
FOLLOW UP ASSESSMENT 105 
Functional Outcome 106 
Main clinical information and data including underlying pathology (primary diagnosis), type 107 
of TEA (primary, revision), follow-up period, pain experience (‘No Pain’, ‘Mild Pain’, 108 
‘Moderate Pain’, ‘Severe Pain’), patient satisfaction (‘Not Satisfied’, ‘Satisfied’, ‘Somewhat 109 
Satisfied’, ‘Very Satisfied’), range of movement (flexion/extension of the elbow and 110 
pronation/supination of the forearm), and complications were collected using a purpose-111 
designed elbow arthroplasty proforma. A validated elbow-specific score, Liverpool Elbow 112 
Score (LES), was used for functional assessment (Appendix1).35,42 The patient-rated section 113 
of the LES has good correlation to the Mayo Elbow Performance Score (MEPS) and has been 114 
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recommended as an outcome measure for evaluating the results of TEA.4 The AO handbook 115 
for Musculoskeletal Outcomes Measures and Instruments rated this score as a superior 116 
quality outcome assessment tool compared to MEPS.39 A score of 0 and 10 indicate worst 117 
and best outcome, respectively. 118 
 119 
Radiographic assessment  120 
Radiographic assessment involved preoperative and post-operative (immediately post-121 
operative; 3, 6, 12 months post-operative; and then annual) anterioposterior and lateral plain 122 
x-rays (Figure.1). Imaging was reviewed for humeral and ulnar stem alignment in sagittal and 123 
coronal planes, aseptic loosening, periprosthetic fracture, dislocation, and hypertropic 124 
ossification. Imaging assessment pattern followed the principles explained in a recent 125 
comprehensive radiographic review of TEA.31 For assessing the component alignment, angles 126 
between the axis of the shaft of humerus and the stem of the humeral component and between 127 
the axis of the shaft of ulna bone and the stem of the ulnar component were measured in the 128 
early post- operative x-rays.13 A malalignment of >10º was considered as significant.11,13,40 129 
Periprosthetic fracture was evaluated based on Mayo Classification System (Figure.2).30 130 
Radiographic and clinical assessments were performed by independent assessors other than 131 
the principal surgeon to eliminate the possibility of information bias. 132 
  133 
Data Analysis 134 
Continuous and descriptive data are reported as mean and standard deviation (Mean + SD) 135 
and 95% confidence interval. Categorical data are described using proportion and percentage. 136 
Paired Student t test or ANOVA were used to compare the preoperative LES and ROM with 137 
those at the final follow-up for the entire patient group and according to underlying pathology 138 
(primary diagnosis) and type of TER (primary, revision), as appropriate. The level of 139 
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significance was set at 5 % (p < 0.05). SPSS package (IBM SPSS Statistics for Windows, 140 
Version 21.0. Armonk, NY: IBM Corp.) was used for data analysis.  141 
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RESULTS 142 
Functional Outcome Results 143 
Preoperatively, 61% and 21% of patients experienced severe and moderate pain, respectively 144 
which was then reduced to 11% and 14% post-operatively. The percentage of pain-free 145 
patients was substantially increased form 7% preoperatively to 64% at the final post-146 
operative follow-up. In terms of patient satisfaction, 63%, 8%, and 23% of patients were 147 
classified as ‘Very Satisfied’, ‘Somewhat Satisfied’, and ‘Satisfied’, respectively. Only 6% 148 
(primary, 5%; revision, 1%) remained unsatisfied with the outcome. 149 
 150 
The mean preoperative and final follow-up LES were 3.79 (±1.71) and 6.36 (±1.85), 151 
respectively which highlighted a significant improvement (p< 0.001). Similar improvements 152 
were observed for all main pathology groups (inflammatory and non-inflammatory arthritis, 153 
and Fracture), however, LES improvement was significantly higher in the primary (6.41±17) 154 
compared to revision TEA (5.78±14) (p<0.05). Table 2 summarises the results of ROM for 155 
flexion and extension of the elbow and pronation and supination of the forearm for entire 156 
patient group and according to the main diagnoses. A significant improvement was noted for 157 
all measured movements except elbow extension (extension deficit). Despite lack of 158 
improvement in the mean elbow extension, flexion-extension arc was significantly improved.  159 
ROM improvements in revision TEA were comparable with those of primary TEA. 160 
Radiographic Assessment Results 161 
Pre-operative and post-operative follow-up (immediately post-op; 3, 6, 12 months post-op; 162 
annual, and the final follow-up) x-rays of 88 TEAs (88%) (primary, 70; revision, 18) were 163 
available for review. Table3 presents the degree of alignment of humeral and ulnar 164 
components (stems) in both sagittal and coronal planes. Around 90% of the evaluated TEAs 165 
presented with a good alignment (<5º) for both components in both planes. A significant 166 
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malalignment (>10º) was seen in one primary TEA elbow; however it was not associated 167 
with early loosening.  168 
The overall incidence of periprosthetic fracture was 14.8% (primary, 6.8%; revision, 8%) 169 
involving humeral condyles and olecranon in 9.1% and 5.7% of elbows, respectively. All 170 
fractures were classified as Mayo Type 1 and managed conservatively. Hypertropic 171 
ossification occurred in 6.8% of TEAs (primary, 5.7%; revision, 1.1%). Areas of non-172 
progressive lucency were noted around the bone-cement interface of 10 primary and seven 173 
revision TEAs without any further progression.  174 
Marked Complications 175 
Marked complications including deep infection, osteolysis/loosening, prosthetic failure, and 176 
permanent ulnar neuropathy occurred in approximately 16% of TEAs of which 13% required 177 
further surgical management. Marked osteolysis around the humeral component was 178 
observed in two of primary and one of revision TEAs; but the prosthesis remained stable with 179 
no need for revision. Four primary TEAs developed significant osteolysis and required 180 
revision of either humeral component (n=3) or both humeral and ulnar components (n=1). 181 
Three revision TEAs developed progressive loosening of both humeral and ulnar 182 
components; two underwent 2nd revision and one is awaiting revision. Deep infection 183 
occurred in 2 cases (both required a 2-stage revision), persistent ulnar neuropathy in 3 cases 184 
(managed with nerve decompression and transposition), and prosthetic failure in 1 case. The 185 
prosthetic failure was of non-traumatic nature and occurred due to the failure of the screws at 186 
the linkage mechanism causing the dissociation of the condyle from main components. This 187 
prosthetic failure was managed by revision surgery and change of the screws. The cause of 188 
this failure was believed to be related to the primary design of the prosthesis which was later 189 
improved.   190 
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DISCUSSION 191 
Despite recent developments in the design of elbow prostheses, advances in surgical 192 
techniques, and marked improvements in pain and function, TEA is still associated with high 193 
complication and revision rates compared to hip and knee arthroplasty.7,41,43 This high 194 
complication rate is partly related to the anatomical characteristics of the elbow such as 195 
insufficient bone stock for implantation and lack of strong supporting soft tissue.3,24  196 
 197 
Elbow prostheses have been used for decades in linked (e.g. Coonrad-Morrey, GSB III, 198 
Triaxial, Discovery System) and unlinked (e.g. Kudo, Souter-Strathclyde, IBP) or both linked 199 
and unlinked (e.g. Acclaim) modes. The Discovery elbow is a linked prosthesis with a design 200 
that mimics the anatomical characteristics and kinematics of the elbow joint. The present 201 
study reports the clinical outcome of TEA with this system over a 4-year mean follow-up and 202 
compares the results with other reports. However, direct comparison of clinical outcomes 203 
amongst different TEA implants is a challenging task because of heterogeneity in reporting 204 
methods of function, pain experience, patient satisfaction, and radiographic assessment.  205 
 206 
Pain relief is one of the prime benefits following any joint arthroplasty. In the present study, 207 
around 64% of cases had no pain at the final follow-up. The majority of the studies on TEA 208 
have used percentage of patients with no pain or mild pain as measure of success of the 209 
procedure. By that standard, 78% of our cases had either no pain or only mild pain at final 210 
follow-up. The percentage of patients with no pain or mild pain after undergoing Acclaim,6 211 
Souter-Strathclyde,33 GSB III15,23,36 and Coonrad-Morrey27,38 have been reported as 64%, 212 
67%, 50–92% and 60-100%, respectively. Overall the patient satisfaction rate for our series 213 
was 94% with 63% of patients reporting maximal satisfaction (Very Satisfied). A study of 214 
different linked prostheses (11 elbows) reported a 73% satisfaction rate.40 In a study of 51 215 
elbows using the Coonrad-Morrey prosthesis, Hildebrand et al,20 reported patient satisfaction 216 
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of 9.2/10 in inflammatory arthritis and 8.6/10 in posttraumatic arthritis. A recent study of 217 
Discovery Elbow replacement patients in 46 elbows reported a patient satisfaction rate of 218 
9.1/10 based on modified American Shoulder and Elbow Surgeons elbow score.18 The study, 219 
however, involved only primary TEAs with majority of them (50%) diagnosed with RA. 220 
 221 
Functional capacity was markedly improved in our cohort of patients according to the LES 222 
which integrates both patient self-evaluation and clinician’s assessments. The LES is a more 223 
recently developed elbow-specific outcome measure and less frequently used compared to the 224 
MEPS in TEA studies. However, it has high responsiveness to the changes following TEA42 225 
and scored higher (9 of 10) than MEPS (6 of 10) against the strength criteria  of an outcome 226 
measure (Content, Methodology, and Clinical Utility) outlined in the AO Handbook 227 
Musculoskeletal Outcomes Measures and Instruments.39 Furthermore, a strong correlation 228 
exists between LES and MEPS4 indicating that marked improvement found for the LES in the 229 
present study are in line with those reported for other prostheses.2,25,27,28,32 The mean 230 
improvement in flexion-extension arc in our TEA series was 21º. Based on systematic 231 
reviews of semiconstrained linked and unlinked TEA prostheses, the average improvement in 232 
flexion-extension arc ranged between 12º-39º with a weighted improvement of 26°.27,41 233 
According to individual studies, the mean improvement in flexion-extension arc with 234 
Acclaim,6 Souter-Strathclyde,33 GSB III,21,23 and Coonrad-Morrey prostheses38 were 23º, 15º, 235 
19º-33º and 17º-26º, respectively. A recent study of 46 Discovery elbows reported an 236 
improvement of 40º in flexion-extension arc.18 The mean improvement in pronation-237 
supination arc in our series was 25º. This movement arc has been reported as 21º-28º for 238 
Coonrad-Morrey prosthesis38 and 31º-67º for GSB III prosthesis.21,23 Hastings et al,18 239 
reported an increase of 29º in pronation-supination arc with Discovery elbow. It has to be 240 
taken into consideration that our reported results combine both primary and revision TEAs.  241 
 242 
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Deep infection remains the most worrying complication with a rate of around 4% infection 243 
reported in longer-term TEA studies.9,27 The overall incidence of deep infection in our series 244 
was 2%. The incidence of deep infection with GSB III TEA has varied between 4%-245 
11%.15,23,36 Studies on Coonrad-Morrey TEA have reported an infection incidence rate of 246 
6%-8%.20,27 Hastings et al,18 recently summarised complications for Coonrad-Morrey, GSB 247 
III, Solar, and Discovery prostheses in 595 TEA patients (561 primary, 34 revision) and cited 248 
the average rate of deep infection as 2.9%. 249 
 250 
While rates of aseptic loosening appears to have improved to less than 10%,42 it remains a 251 
major cause of revision following TEA. Progressive aseptic loosening requiring revision 252 
occurred in 4 primary (5%) and 3 revision (12%) patients of our series. In primary group, 253 
humeral and ulnar components were affected in three and one cases, respectively. In revision 254 
group both components were affected. Six of aseptic loosening cases underwent revision 255 
surgery with Discovery elbow and remained stable by the time of final follow-up, one case is 256 
awaiting revision. This complication has been reported in association with other linked 257 
prostheses including Coonrad-Morrey (0%-7%),1,14,16,20,27 GSB III (4%-29%),8,15,21,36 and 258 
Souter-Strathclyde (up to 31%).16,25,32 Summarising the complication reports from linked 259 
devices, Hastings et al,18 and Kelly et al,23 have cited the average rate of primary aseptic 260 
loosening as 8.9% and 4%-50%, respectively. In a recently published study of 46 Discovery 261 
elbow cases, aseptic loosening of the humeral component developed in 1 patient (2.2%) 262 
without need to revision.18 The study however, reported revision of a severe loosening case of 263 
humeral component together with associated condyles and bearing in another patient who did 264 
not meet study population inclusion criteria. Another study of Discovery elbow (18 cases) 265 
reported an aseptic loosening (5.6%) due to inadequate cementing of the ulnar component 17 266 
months following TEA which required revision surgery.10  267 
  268 
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The overall rate of periprosthetic fracture was 14.8% (primary, 6.8%; revision, 8%) in the 269 
present study. All fractures were classified as Mayo Type 1 and required conservative 270 
management. The incidence of periprosthetic fractures with Acclaim,6 GSB III,21,36 and 271 
Coonrad-Morrey20 has been reported as 36%, 16%-21%, and 23%, respectively.  272 
 273 
Incidence of persistent ulnar neuropathy requiring surgical intervention was 3% in our series. 274 
Ulnar neuropathy is seen more commonly in rheumatoid arthritis as close proximity of the 275 
nerve to the elbow joint can lead to inflammation of the nerve due to synovitis in the nearby 276 
elbow joint and valgus instability can lead to stretching of the ulnar nerve.29 The incidence 277 
rate of ulnar neuropathy with GSB III, Coonrad-Morrey, and Acclaim has been reported as 278 
11%-14%,8,23 12%-26%,1,20 and 8%,6 respectively. Summarising the complications of TEA in 279 
595 patients, Hastings et al,18 cited a rate of 4.4% for ulnar neuropathy.  280 
 281 
The present study provided comprehensive prospective clinical outcome data on for the 282 
Discovery elbow arthroplasty. The study included a large cohort of primary and revision 283 
TEAs which reduced the scope of selection bias. Furthermore, performing clinical and 284 
radiographic assessments by independent assessors decreased the possibility of information 285 
bias. There were, however, some limitations to the study. First, study included both primary 286 
and revision TEAs which might have some effect on reported outcome results. In order to 287 
address this, significant differences between primary and revision TEAs in outcome measures 288 
(e.g. LES) and complications rates are highlighted in the paper. Second, study used LES as a 289 
key functional assessment tool. This reduced the scope of comparisons with other studies into 290 
some extent as based around half of recent outcome reports used MEPS.27 Hence, MEPS was 291 
added into our functional assessment tools a few years ago and being completed in addition 292 
to LES for all prospective TEAs. Third, a 4-year mean follow-up provides a relatively 293 
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reasonable period for functional outcome report but a longer term follow-up is required for 294 
assessing late complications and survivorship of the prosthesis.    295 
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CONCLUSION 296 
The results indicate that Discovery elbow is a system viable option for the treatment of 297 
advanced inflammatory and non-inflammatory elbow conditions where a TEA is indicated. 298 
This was reflected in significant improvements in LES, range of movement, pain experience, 299 
and a high patient satisfaction score at a 4-year mean follow-up. The incidence of 300 
complications was either comparable or less than that reported for other linked prostheses. 301 
We need to wait for the long term results of this prosthesis to assess its survivorship.  302 
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Figure and Table Legends 419 
Figure1. Lateral and anteroposterior x-rays of an elbow with osteoarthritis before (a-b) and 420 
6-year after total elbow arthroplasty with Discovery Elbow (c-d). 421 
Figure2. Graphic illustration of the Mayo Clinic classification system used for describing 422 
periprosthetic fractures in elbow arthroplasty. It is important to differentiate between different 423 
types of fractures as those affecting the hardware stems (types 2 and 3) will potentially 424 
require revision. (Reprinted with permission from RadioGraphics.31  425 
Table1. Incidence of diagnoses for primary and revision Total Elbow Arthroplasty (TEA) 426 
Table2. Comparison of the mean (SD) pre- and postoperative elbow and forearm ROM with 427 
Discovery Elbow according to main underlying pathologies in all patients (primary and 428 
revision) 429 
Table3. Prosthesis alignment in primary and revision Total Elbow Arthroplasty (TEA) 430 
 Table1. Incidence of diagnoses for primary and revision Total Elbow Arthroplasty (TEA)  
 
Main Diagnoses and sub-diagnoses 
Incidence (%) 
(n = 100 elbows) 
Inflammatory Arthritis  
          Rheumatoid Arthritis 54 
          Juvenile Rheumatoid Arthritis 2 
         Psoriatic Arthritis 2 
 
Non-Inflammatory Arthritis  
          Degenerative Osteoarthritis 17 
          Traumatic Arthritis 14 
          Haemophilic Arthropathy 3 
         Nail–patella syndrome    1 
 
Distal Humerus Fracture (acute and non-union) 7 
Total TEA 100 
 
 
Revision TEA  
          Inflammatory Arthritis 16 
         Non-Inflammatory Arthritis 7 
         Fracture 2 
 
Total 25 
 
 
Table2. Comparison of the mean (SD) pre- and postoperative elbow and forearm ROM with Discovery 
Elbow according to main underlying pathologies in all patients (primary and revision) 
 
Elbow/Forearm 
ROM 
All Patients  Non-Inflammatory 
(Osteoarthritis) 
Inflammatory 
(Rheumatoid Arthritis) 
Fracture 
Pre-op Post-op Pre-op Post-op Pre-op Post-op Pre-op Post-op 
Flexion 100 (24) 118 (17)** 101 (26) 118 (18) * 100 (20) 117 (16)** 92 (38) 115 (28) 
Extension lag 28 (14) 25 (14) 28 (11) 25 (12) 28 (16) 26 (16) 23 (15) 18 (17) 
FLX-EXT ARC 72 (28) 93 (27)** 73 (30) 93 (26)* 72 (27) 92 (26)** 87 (33) 97 (44) 
Pronation 48 (23) 61 (21)** 49 (25) 64 (18)* 46 (23) 59 (22)* 61 (17) 64 (15) 
Supination 38 (26) 50 (25)** 42 (26) 55 (21)* 35 (26) 45 (25)* 52 (23) 51 (29) 
PRON-SUP ARC 86 (45) 111 (42)** 91 (48) 119 (35)** 81 (44) 104 (42)* 113 (39) 115 (41) 
 
-SD, Standard Deviation; FLX, Flexion; EXT, Extension; ROM, Range of Motion; Pre-op, Preoperative; 
Post-op, Postoperative.  
-Significant difference at P < .05 (*) and P < .001 (**). 
 
Table3. Prosthesis alignment in primary and revision Total Elbow Arthroplasty (TEA) 
Degree of Malalignment 
Coronal Plane Sagittal Plane 
Humerus Ulna Humerus Ulna 
 
PRIMARY TEA 
Less than 5 degrees  61 57 48 63 
5-10 degrees  9 13 22 6 
More than 10 degrees  0 0 0 1 
 
REVISION TEA 
Less than 5 degrees  16 16 14 17 
5-10 degrees  2 2 4 1 
More than 10 degrees  0 0 0 0 
 
 


1 
 
Figure and Table Legends 
Figure1. Lateral and anteroposterior x-rays of an elbow with osteoarthritis before (a-b) and 6-year 
after total elbow arthroplasty with Discovery Elbow (c-d). 
Figure2. Graphic illustration of the Mayo Clinic classification system used for describing 
periprosthetic fractures in elbow arthroplasty. It is important to differentiate between different types 
of fractures as those affecting the hardware stems (types 2 and 3) will potentially require revision. 
(Reprinted with permission from RadioGraphics.29  
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Table2. Comparison of pre- and postoperative elbow and forearm range of motion with Discovery 
Elbow according to main underlying pathologies in all patients (primary and revision) 
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